April 14, 2023
Physics World highlighted research led by the University of Cincinnati's Nalinikanth Kotagiri that shows a proof of concept for using engineered bacteria as an adapter to deliver targeted radionuclide treatment to tumors.
October 19, 2023
The University of Cincinnati’s Timothy Phoenix is one of the investigators on a research team that is part of a new NCI Pediatric Immunotherapy Network and studying how to improve immunotherapy treatments for pediatric brain tumors.
September 23, 2022
The University of Cincinnati's Pankaj Desai, PhD, has received a $1.19 million grant from the National Institutes of Health/National Institute of Neurological Disorders and Stroke to continue research into the use of a drug called letrozole to treat glioblastomas, the most deadly form of brain tumors.
January 3, 2024
The Cincinnati Enquirer reported on new harm reduction vending machines operated by Hamilton County Public Health, citing University of Cincinnati research that the vending machines increase accessibility to harm reduction products and services.
December 19, 2022
National and local media outlets highlighted the partnership between the University of Cincinnati's Dan Arendt and Cincinnati nonprofit Caracole, who have installed a harm reduction vending machine that helps prevent overdoses in Hamilton County.
December 6, 2022
The University of Cincinnati's Daniel Arendt has published new research that shows a self-service vending machine filled with harm reduction supplies such as naloxone helped prevent overdoses and contributed to Hamilton County’s overdose deaths decreasing in 2021.
March 26, 2024
A multidisciplinary team of University of Cincinnati Cancer Center researchers have opened a Phase 2 clinical trial to test a new combination treatment for glioblastomas, the most deadly form of brain tumors.
March 24, 2025
The University of Cincinnati Cancer Center’s Timothy Phoenix, PhD; Pratiti (Mimi) Bandopadhayay, MBBS, PhD, of Dana-Farber Cancer Institute; and David Jones, PhD, of the German Cancer Research Center have been awarded a $1.2 million grant from the Team Jack Foundation to study pediatric low-grade gliomas.
March 28, 2025
The Cincinnati Business Courier highlighted a $1.2 million grant received by the University of Cincinnati Cancer Center's Timothy Phoenix and colleagues at Dana-Farber Cancer Institute and the German Cancer Research Center to study pediatric low-grade gliomas.
December 2, 2024
United Press International, Yahoo News and MSN highlighted research from the University of Cincinnati's Daniel Arendt in a story on the rise of harm reduction vending machines across the country.